Navigation Links
Astra Nova and ACRES Partner on Quality and Access of Training for Research Professionals
Date:7/23/2014

Cambridge, MA (PRWEB) July 23, 2014

Astra Nova Training, a global provider of innovative and comprehensive consultancy and pharma training services, and the Alliance for Clinical Research Excellence and Safety (ACRES), a non-profit integrating the expertise and investments of research stakeholders worldwide to build and maintain a global system for clinical trials, are pleased to announce a strategic alliance collaboration to improve the expertise of industry professionals through improved and easily available training quality, thus enhancing greater patient safety.

Since its establishment in 2008, UK-based Astra Nova has introduced an international network of over 140 industry experts based in over 50 countries around the globe. In addition, the company has launched over 20 free and commercial online training courses, accessible on their Learning Management System. More than 5,000 professionals worldwide have obtained industry certification through their in-house and online training solutions.

ACRES, a non-profit organization operating in the public interest, is dedicated to enhancing quality, safety, integrity, and operational effectiveness in drug development and health research through the building of a global system for clinical research. To achieve this, ACRES has adopted an Alliance-based model whereby those organizations with a stake in clinical trials being conducted according to the highest standards of safety, quality, and efficiency, are the very organizations that—together—build the comprehensive, integrated system to make such excellence possible.

Astra Nova, with its strong commitment to corporate social responsibility (CSR), will make available interactive and easy-to access online training solutions for ACRES Global Platform of services. This CSR commitment, mirrored by ACRES, is exemplified in Astra Nova’s Better Industry Initiative (Bii), which provides free and commercial high-quality training courses and other resources, with an ultimate goal of better serving patients by equipping future and current industry professionals with more refined skills and workflow efficiency tools.

With Astra Nova, ACRES will provide timely information on critical training topics and materials needed globally, and they will partner on Learning Management Systems development. Other collaborative efforts involve jointly organizing multi-stakeholder events dedicated to improving the conduct of clinical research globally.

Astra Nova’s Business Development Director, Ms. Maya Zlatanova, said: “Our main goal is to improve patient safety and allow easier access to industry regulations, standards, and knowledge. We believe that everyone will benefit from this partnership, and the results of this collaboration will become visible in the very first days of establishing it.”

Dr Matthew Whalen, COO of ACRES, noted, “ACRES work is conducted through alliances, and Astra Nova brings added depth to ACRES network of organizations committed to transforming the world of clinical research.” Whalen added, “We are looking forward to working together with Astra Nova in a variety of ways to realize our shared collaboration goal of providing more innovative solutions, broader standardization, better quality of service, greater safety, and increased efficiency.”

ASTRA NOVA LTD:

More information on Astra Nova’s work can be found here. For more information, please contact Ms. Maya Zlatanova at maya(at)astranovatraining(dot)co(dot)uk.

ACRES:

More information on the Alliance for Clinical Research Excellence and Safety (ACRES) may be found here. For more information, please contact Dr. Mary F. Tobin at mtobin(at)acresglobal(dot)net.

Read the full story at http://www.prweb.com/releases/ACRES_AstraNova_Research/GregKoskiMayaZlatanove/prweb12035287.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related biology technology :

1. Genedata Announces Collaboration With AstraZeneca on the Analysis of Compound Combination Experiments
2. New Drug Applications, FDA Approvals, Approved Acquisitions, Divestitures and Licensing Agreements - Research Report on Merck, Allergan, Mylan, AstraZeneca, and GlaxoSmithKline
3. Global Lung Cancer Therapeutics Market 2013 Report Featuring Leading Players Such As AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Co., GlaxoSmithKline, Hoffmann-La Roche, Novartis And Others
4. Todays Technical View: AstraZeneca, GlaxoSmithKline, Keryx Biopharma, and Raptor Pharma
5. Top Five Global Cardiovascular Drug Companies 2013 Report Features Players such as Pfizer and AstraZeneca
6. Amgen And AstraZeneca Highlight Data To Be Presented At European League Against Rheumatism Annual Meeting
7. Isis Pharmaceuticals Earns $10 Million Milestone Payment from AstraZeneca for ISIS-AR Rx to Treat Prostate Cancer
8. Surveyed Physicians Indicate that Xtandi is Prescribed to Nearly One Quarter of Metastatic Castrate-Resistant Prostate Cancer Patients Who Have Failed to Respond to Prior Docetaxel Treatment
9. Delta Point Strengthens Management and Expands Consultancy Services with Addition of Former AstraZeneca Executive Michael Hickey
10. UroToday Launches New Prostate Cancer Focused Content Including Immunotherapy for Metastatic Castration-resistant Patients
11. AstraZeneca Announces Top-line Phase III Results from Naloxegol Pivotal Trials In Patients With Opioid-Induced Constipation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2016)... ... May 19, 2016 , ... KCAS Bioanalytical and ... Siddiqui as Director, Large Molecule & Biomarker Bioanalysis. , Dr. Siddiqui has more ... discovery studies for preclinical and clinical safety programs. “We’ve seen significant demand for, ...
(Date:5/19/2016)... 2016 - I dati saranno ... il 52 ° Congresso della ... - Le conclusioni dello studio indicano un tasso ... di cui il 90% presenta una d urata della ... Il settantadue per cento dei pazienti ha riscontrato un beneficio ...
(Date:5/18/2016)... , ... May 18, 2016 , ... ... Sciences Summer Camp at The University of Toledo. This two-day camp will take ... opportunity to explore the field of pharmaceutical sciences in preparation for a university ...
(Date:5/18/2016)... ... 2016 , ... STACS DNA Inc., the sample tracking software company, today announced ... kit processing to help them save time and reduce errors. , Sexual Assault kits ... processed and victims informed of results. Due to a previous lack of tools, many ...
Breaking Biology Technology:
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
(Date:3/17/2016)... ABI Research, the leader in transformative ... market will reach more than $30 billion by ... Consumer electronics, particularly smartphones, continue to boost the ... reach two billion shipments by 2021 at a ... Research Analyst at ABI Research. "Surveillance is also ...
(Date:3/14/2016)... http://www.apimages.com ) - ... - Renvoi : image disponible via AP Images ( ... --> DERMALOG, le leader de l,innovation ... d,empreintes digitales pour l,enregistrement des réfugiés en Allemagne. ... produire des cartes d,identité aux réfugiés. DERMALOG dévoilera ...
Breaking Biology News(10 mins):